gbr 13119 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
*1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. [MeSH]
*1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. [MeSH]
| Studies (gbr 13119) | Trials (gbr 13119) | Recent Studies (post-2010) (gbr 13119) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 3,859 | 8 | 1,052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kilbourn, MR; Mulholland, GK; Pisani, T; Sherman, PS | 1 |
| Haka, MS; Kilbourn, MR; Mulholland, GK; Pisani, T; Sherman, PS | 1 |
2 other study(ies) available for gbr 13119 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Dopamine; Fluorine Radioisotopes; Ligands; Male; Mice; Mice, Inbred C57BL; Piperazines | 1991 |
Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neurotransmitter Uptake Inhibitors; Piperazines | 1989 |